Digital Is VR the answer to the great wait? Over 6.3 million patients make up the NHS backlog for consultant-led elective care, which reached 7,573,212 in September 2024.
Digital AI helps with more precise surgery While artificial intelligence has proven to be a valuable tool for automating repetitive, laborious tasks, it has also become a valuable resource for simplifying complex tasks.
News BioNTech to buy rival mRNA firm CureVac for $1.25bn BioNTech has agreed to buy another specialist in mRNA medicines, fellow German biotech CureVac, for around $1.25 billion.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
